These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29467872)

  • 41. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer.
    Han X; Li Q; Liu C; Wang C; Li Y
    J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell.
    Lee S; Lee H; Jeong D; Ham J; Park S; Choi EH; Kim SJ
    Free Radic Biol Med; 2017 Sep; 110():280-290. PubMed ID: 28666851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
    Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
    Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA H19 mediates N-acetyltransferase 1 gene methylation in the development of tamoxifen resistance in breast cancer.
    Sun H; Wang G; Cai J; Wei X; Zeng Y; Peng Y; Zhuang J
    Exp Ther Med; 2022 Jan; 23(1):12. PubMed ID: 34815764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
    Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
    Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.
    Cheng S; Castillo V; Welty M; Alvarado M; Eliaz I; Temm CJ; Sandusky GE; Sliva D
    BMC Complement Altern Med; 2017 Feb; 17(1):115. PubMed ID: 28209156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.
    Chen J; Chen Z; Huang J; Chen F; Ye W; Ding G; Wang X
    Oncol Lett; 2018 Mar; 15(3):3017-3023. PubMed ID: 29435032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7/ADR cells through suppressing the expression of ABC transport proteins.
    Pan X; Yang X; Zang J; Zhang S; Huang N; Guan X; Zhang J; Wang Z; Li X; Lei X
    Oncol Lett; 2017 Jun; 13(6):4785-4793. PubMed ID: 28599480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long Non-coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis.
    Qu R; Hu C; Tang Y; Yu Q; Shi G
    Cancer Manag Res; 2020; 12():1771-1777. PubMed ID: 32210618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of miRNA in 5-FU resistant esophageal cancer.
    Mahawongkajit P; Tomtitchong P
    Mol Clin Oncol; 2020 Aug; 13(2):221-227. PubMed ID: 32714549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
    BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of miRNAs 34a, 146a, 320a and 542 in the synergistic anticancer effects of methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) with doxorubicin in breast cancer cells.
    Hasanpourghadi M; Abdul Majid N; Rais Mustafa M
    PeerJ; 2018; 6():e5577. PubMed ID: 30245930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
    Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM
    Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival.
    Young J; Kawaguchi T; Yan L; Qi Q; Liu S; Takabe K
    Oncotarget; 2017 Nov; 8(59):99978-99989. PubMed ID: 29245954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
    Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
    Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.